Imexpharm Corporation (HOSE:IMP)
50,100
+1,550 (3.19%)
At close: Oct 31, 2025
Imexpharm Market Cap
Imexpharm has a market cap or net worth of 7.72 trillion as of October 31, 2025. Its market cap has increased by 7.08% in one year.
Market Cap
7.72T
Enterprise Value
7.69T
Revenue
2.45T
Ranking
n/a
PE Ratio
23.16
Stock Price
50,100.00
Market Cap Chart
Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 7.72T, an increase of 595.87%. That is a compound annual growth rate of 11.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 7.72T | 6.60% |
| Dec 31, 2024 | 7.24T | 82.69% |
| Dec 29, 2023 | 3.96T | -1.28% |
| Dec 30, 2022 | 4.01T | -22.62% |
| Dec 31, 2021 | 5.19T | 38.19% |
| Dec 31, 2020 | 3.75T | 58.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition